Find a Commonwealth Resource
Obiltoxaximab
HealthData.Gov
Updated Jun 12, 2026
About this dataset
Anthim (obiltoxaximab) is a prescription monoclonal antibody used to treat inhalation anthrax in combination with antibiotics. It's administered intravenously as a single-dose injection. Manufactured by Elusys Therapeutics, Inc., it was approved by the FDA in 2016. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Obiltoxaximab
Access the FDA dataset for Obiltoxaximab — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025